Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Immuno-oncology Drugs Market 2018, Forecast to 2023

  • receipt Report ID : 141373
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 146
  • list Pharmaceuticals and Healthcare

Scope of the Report:

This report focuses on the Immuno-oncology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Immuno-oncology Drugs is expected to grow at a CAGR of roughly 14.2% over the next five years, will reach 109200 million US$ in 2023, from 49200 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

Amgen, Inc

AstraZeneca, Plc

Bristol-Myers Squibb

Celgene Corporation

Eli Lilly and Company

Merck & Co.

Hoffmann-La Roche AG

Johnson & Johnson

Novartis International AG

AbbVie, Inc.

Pfizer Inc.

Sanofi S.A.

EMD Serono, Inc.

Gilead Sciences Inc.

Prometheus Therapeutics & Diagnostics

Aduro BioTech

Galena Biopharma

Bavarian Nordic

Celldex Therapeutics

ImmunoCellular Therapeutics

Incyte

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Immune Checkpoint Inhibitors

Monoclonal Antibodies

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy

Market Segment by Applications, can be divided into

Hospitals

Pharmacies

Online Pharmacies

There are 15 Chapters to deeply display the global Immuno-oncology Drugs market.

Chapter 1, to describe Immuno-oncology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Immuno-oncology Drugs, with sales, revenue, and price of Immuno-oncology Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Immuno-oncology Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Immuno-oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Immuno-oncology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Immuno-oncology Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Immune Checkpoint Inhibitors

1.2.2 Monoclonal Antibodies

1.2.3 Cytokine-Based Immunotherapy

1.2.4 Cancer Vaccines

1.2.5 CAR-T Cell Therapy

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Pharmacies

1.3.3 Online Pharmacies

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen, Inc

2.1.1 Business Overview

2.1.1.1 Amgen, Inc Description

2.1.1.2 Amgen, Inc Headquarter, Main Business and Finance Overview

2.1.2 Amgen, Inc Immuno-oncology Drugs Product Introduction

2.1.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.1.2.2 Immuno-oncology Drugs Product Information

2.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.1 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.2 Global Amgen, Inc Immuno-oncology Drugs Market Share in 2017

2.2 AstraZeneca, Plc

2.2.1 Business Overview

2.2.1.1 AstraZeneca, Plc Description

2.2.1.2 AstraZeneca, Plc Headquarter, Main Business and Finance Overview

2.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Introduction

2.2.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.2.2.2 Immuno-oncology Drugs Product Information

2.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.1 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.2 Global AstraZeneca, Plc Immuno-oncology Drugs Market Share in 2017

2.3 Bristol-Myers Squibb

2.3.1 Business Overview

2.3.1.1 Bristol-Myers Squibb Description

2.3.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview

2.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Introduction

2.3.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.3.2.2 Immuno-oncology Drugs Product Information

2.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.1 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.2 Global Bristol-Myers Squibb Immuno-oncology Drugs Market Share in 2017

2.4 Celgene Corporation

2.4.1 Business Overview

2.4.1.1 Celgene Corporation Description

2.4.1.2 Celgene Corporation Headquarter, Main Business and Finance Overview

2.4.2 Celgene Corporation Immuno-oncology Drugs Product Introduction

2.4.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.4.2.2 Immuno-oncology Drugs Product Information

2.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.1 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.2 Global Celgene Corporation Immuno-oncology Drugs Market Share in 2017

2.5 Eli Lilly and Company

2.5.1 Business Overview

2.5.1.1 Eli Lilly and Company Description

2.5.1.2 Eli Lilly and Company Headquarter, Main Business and Finance Overview

2.5.2 Eli Lilly and Company Immuno-oncology Drugs Product Introduction

2.5.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.5.2.2 Immuno-oncology Drugs Product Information

2.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.1 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.3.2 Global Eli Lilly and Company Immuno-oncology Drugs Market Share in 2017

2.6 Merck & Co.

2.6.1 Business Overview

2.6.1.1 Merck & Co. Description

2.6.1.2 Merck & Co. Headquarter, Main Business and Finance Overview

2.6.2 Merck & Co. Immuno-oncology Drugs Product Introduction

2.6.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.6.2.2 Immuno-oncology Drugs Product Information

2.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.1 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.3.2 Global Merck & Co. Immuno-oncology Drugs Market Share in 2017

2.7 Hoffmann-La Roche AG

2.7.1 Business Overview

2.7.1.1 Hoffmann-La Roche AG Description

2.7.1.2 Hoffmann-La Roche AG Headquarter, Main Business and Finance Overview

2.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Introduction

2.7.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.7.2.2 Immuno-oncology Drugs Product Information

2.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.3.1 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.3.2 Global Hoffmann-La Roche AG Immuno-oncology Drugs Market Share in 2017

2.8 Johnson & Johnson

2.8.1 Business Overview

2.8.1.1 Johnson & Johnson Description

2.8.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview

2.8.2 Johnson & Johnson Immuno-oncology Drugs Product Introduction

2.8.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.8.2.2 Immuno-oncology Drugs Product Information

2.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.3.1 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.3.2 Global Johnson & Johnson Immuno-oncology Drugs Market Share in 2017

2.9 Novartis International AG

2.9.1 Business Overview

2.9.1.1 Novartis International AG Description

2.9.1.2 Novartis International AG Headquarter, Main Business and Finance Overview

2.9.2 Novartis International AG Immuno-oncology Drugs Product Introduction

2.9.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.9.2.2 Immuno-oncology Drugs Product Information

2.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.3.1 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.3.2 Global Novartis International AG Immuno-oncology Drugs Market Share in 2017

2.10 AbbVie, Inc.

2.10.1 Business Overview

2.10.1.1 AbbVie, Inc. Description

2.10.1.2 AbbVie, Inc. Headquarter, Main Business and Finance Overview

2.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Introduction

2.10.2.1 Immuno-oncology Drugs Production Bases, Sales Regions and Major Competitors

2.10.2.2 Immuno-oncology Drugs Product Information

2.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10.3.1 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10.3.2 Global AbbVie, Inc. Immuno-oncology Drugs Market Share in 2017

2.11 Pfizer Inc.

2.11.1 Business Overview

2.11.2 Pfizer Inc. Immuno-oncology Drugs Product Introduction

2.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Sanofi S.A.

2.12.1 Business Overview

2.12.2 Sanofi S.A. Immuno-oncology Drugs Product Introduction

2.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 EMD Serono, Inc.

2.13.1 Business Overview

2.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Introduction

2.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Gilead Sciences Inc.

2.14.1 Business Overview

2.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Introduction

2.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Prometheus Therapeutics & Diagnostics

2.15.1 Business Overview

2.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Introduction

2.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Aduro BioTech

2.16.1 Business Overview

2.16.2 Aduro BioTech Immuno-oncology Drugs Product Introduction

2.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 Galena Biopharma

2.17.1 Business Overview

2.17.2 Galena Biopharma Immuno-oncology Drugs Product Introduction

2.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18 Bavarian Nordic

2.18.1 Business Overview

2.18.2 Bavarian Nordic Immuno-oncology Drugs Product Introduction

2.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.19 Celldex Therapeutics

2.19.1 Business Overview

2.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Introduction

2.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.20 ImmunoCellular Therapeutics

2.20.1 Business Overview

2.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Introduction

2.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.21 Incyte

2.21.1 Business Overview

2.21.2 Incyte Immuno-oncology Drugs Product Introduction

2.21.3 Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Immuno-oncology Drugs Market Competition, by Manufacturer

3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Global Immuno-oncology Drugs Price by Manufacturer (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Immuno-oncology Drugs Manufacturer Market Share in 2017

3.4.2 Top 5 Immuno-oncology Drugs Manufacturer Market Share in 2017

3.5 Market Competition Trend

4 Global Immuno-oncology Drugs Market Analysis by Regions

4.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Immuno-oncology Drugs Sales by Regions (2013-2018)

4.1.2 Global Immuno-oncology Drugs Revenue by Regions (2013-2018)

4.2 North America Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)

4.3 Europe Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)

4.5 South America Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Growth Rate (2013-2018)

5 North America Immuno-oncology Drugs by Countries, Type, Application and Manufacturers

5.1 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Immuno-oncology Drugs Sales by Countries (2013-2018)

5.1.2 North America Immuno-oncology Drugs Revenue by Countries (2013-2018)

5.1.3 United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

5.1.4 Canada Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

5.1.5 Mexico Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

5.2 North America Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

5.2.1 North America Immuno-oncology Drugs Sales by Manufacturers (2016-2017)

5.2.2 North America Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)

5.3 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)

5.3.1 North America Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)

5.3.2 North America Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)

5.4 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)

5.4.1 North America Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)

5.4.2 North America Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)

6 Europe Immuno-oncology Drugs by Countries, Type, Application and Manufacturers

6.1 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Immuno-oncology Drugs Sales by Countries (2013-2018)

6.1.2 Europe Immuno-oncology Drugs Revenue by Countries (2013-2018)

6.1.3 Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

6.1.4 UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

6.1.5 France Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

6.1.6 Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

6.1.7 Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

6.2 Europe Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

6.2.1 Europe Immuno-oncology Drugs Sales by Manufacturers (2016-2017)

6.2.2 Europe Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)

6.3 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)

6.3.1 Europe Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)

6.3.2 Europe Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)

6.4 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)

6.4.1 Europe Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)

6.4.2 Europe Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)

7 Asia-Pacific Immuno-oncology Drugs by Countries, Type, Application and Manufacturers

7.1 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Immuno-oncology Drugs Sales by Countries (2013-2018)

7.1.2 Asia-Pacific Immuno-oncology Drugs Revenue by Countries (2013-2018)

7.1.3 China Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

7.1.4 Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

7.1.5 Korea Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

7.1.6 India Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

7.1.7 Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

7.2 Asia-Pacific Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

7.2.1 Asia-Pacific Immuno-oncology Drugs Sales by Manufacturers (2016-2017)

7.2.2 Asia-Pacific Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)

7.3 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)

7.3.1 Asia-Pacific Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)

7.3.2 Asia-Pacific Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)

7.4 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)

7.4.1 Asia-Pacific Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)

7.4.2 Asia-Pacific Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)

8 South America Immuno-oncology Drugs by Countries, Type, Application and Manufacturers

8.1 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Immuno-oncology Drugs Sales by Countries (2013-2018)

8.1.2 South America Immuno-oncology Drugs Revenue by Countries (2013-2018)

8.1.3 Brazil Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

8.1.4 Argentina Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

8.1.5 Colombia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

8.2 South America Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

8.2.1 South America Immuno-oncology Drugs Sales by Manufacturers (2016-2017)

8.2.2 South America Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)

8.3 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)

8.3.1 South America Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)

8.3.2 South America Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)

8.4 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)

8.4.1 South America Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)

8.4.2 South America Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)

9 Middle East and Africa Immuno-oncology Drugs by Countries, Type, Application and Manufacturers

9.1 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Countries (2013-2018)

9.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2013-2018)

9.1.3 Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

9.1.4 UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

9.1.5 Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

9.1.6 Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

9.1.7 South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

9.2 Middle East and Africa Immuno-oncology Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

9.2.1 Middle East and Africa Immuno-oncology Drugs Sales by Manufacturers (2016-2017)

9.2.2 Middle East and Africa Immuno-oncology Drugs Revenue by Manufacturers (2016-2017)

9.3 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)

9.3.1 Middle East and Africa Immuno-oncology Drugs Sales and Sales Share by Type (2013-2018)

9.3.1 Middle East and Africa Immuno-oncology Drugs Revenue and Revenue Share by Type (2013-2018)

9.4 Middle East and Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Application (2013-2018)

9.4.1 Middle East and Africa Immuno-oncology Drugs Sales and Sales Share by Application (2013-2018)

9.4.2 Middle East and Africa Immuno-oncology Drugs Revenue and Revenue Share by Application (2013-2018)

10 Global Immuno-oncology Drugs Market Segment by Type

10.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Immuno-oncology Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018)

10.2 Immune Checkpoint Inhibitors Sales Growth and Price

10.2.1 Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)

10.2.2 Global Immune Checkpoint Inhibitors Price (2013-2018)

10.3 Monoclonal Antibodies Sales Growth and Price

10.3.1 Global Monoclonal Antibodies Sales Growth (2013-2018)

10.3.2 Global Monoclonal Antibodies Price (2013-2018)

10.4 Cytokine-Based Immunotherapy Sales Growth and Price

10.4.1 Global Cytokine-Based Immunotherapy Sales Growth (2013-2018)

10.4.2 Global Cytokine-Based Immunotherapy Price (2013-2018)

10.5 Cancer Vaccines Sales Growth and Price

10.5.1 Global Cancer Vaccines Sales Growth (2013-2018)

10.5.2 Global Cancer Vaccines Price (2013-2018)

10.6 CAR-T Cell Therapy Sales Growth and Price

10.6.1 Global CAR-T Cell Therapy Sales Growth (2013-2018)

10.6.2 Global CAR-T Cell Therapy Price (2013-2018)

11 Global Immuno-oncology Drugs Market Segment by Application

11.1 Global Immuno-oncology Drugs Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Pharmacies Sales Growth (2013-2018)

11.4 Online Pharmacies Sales Growth (2013-2018)

12 Immuno-oncology Drugs Market Forecast (2018-2023)

12.1 Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Immuno-oncology Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Immuno-oncology Drugs Market Forecast (2018-2023)

12.2.2 Europe Immuno-oncology Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Immuno-oncology Drugs Market Forecast (2018-2023)

12.2.4 South America Immuno-oncology Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Immuno-oncology Drugs Market Forecast (2018-2023)

12.3 Immuno-oncology Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2018-2023)

12.4 Immuno-oncology Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Immuno-oncology Drugs Picture

Table Product Specifications of Immuno-oncology Drugs

Figure Global Immuno-oncology Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery